Concepedia

Publication | Closed Access

209P Interim results of a phase I/Ib study of SBT6050 monotherapy and pembrolizumab combination in patients with advanced HER2-expressing or amplified solid tumors

26

Citations

0

References

2021

Year

No additional data available for this publication yet. Check back later!